nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)
|
Hainsworth, John D. |
|
2016 |
11 |
5 |
p. 643-653 |
artikel |
2 |
Ceritinib: a Review in ALK-Positive Advanced NSCLC
|
Deeks, Emma D. |
|
2016 |
11 |
5 |
p. 693-700 |
artikel |
3 |
Combinatorial Study of a Novel Poly (ADP-ribose) Polymerase Inhibitor and an HDAC Inhibitor, SAHA, in Leukemic Cell Lines
|
Hegde, Mahesh |
|
2016 |
11 |
5 |
p. 655-665 |
artikel |
4 |
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
|
Mässenhausen, Anne von |
|
2016 |
11 |
5 |
p. 631-642 |
artikel |
5 |
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer
|
Modena, Alessandra |
|
2016 |
11 |
5 |
p. 569-577 |
artikel |
6 |
Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer
|
Kristeleit, Hartmut |
|
2016 |
11 |
5 |
p. 579-591 |
artikel |
7 |
Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer
|
Pluchart, H. |
|
2016 |
11 |
5 |
p. 687-691 |
artikel |
8 |
Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast Cancer
|
Vaidyanathan, Srividya |
|
2016 |
11 |
5 |
p. 677-686 |
artikel |
9 |
Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial
|
Arrieta, Oscar |
|
2016 |
11 |
5 |
p. 619-629 |
artikel |
10 |
Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of Everolimus
|
Pavel, Marianne |
|
2016 |
11 |
5 |
p. 667-675 |
artikel |
11 |
Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment
|
Ishihara, Hiroki |
|
2016 |
11 |
5 |
p. 605-617 |
artikel |
12 |
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?
|
Puzzoni, Marco |
|
2016 |
11 |
5 |
p. 593-603 |
artikel |